3rd ESTRO Forum 2015 S303 different diffusion-sensitizing gradients (b = 0, 200 and 800 s/mm 2 ). The median tumor apparent diffusion coefficient (ADC) was determined at the three time points. The predictive potential of initial ADC, and change in ADC (ΔADC) during and after treatment for pathologic complete response (pathCR) and good response (GR) was assessed. Good response was defined as pathCR or near-pathCR (tumor regression grade [TRG] 1 or 2). Results: A pathCR after nCRT was found in 4 of 20 patients (20%), and 8 patients (40%) showed a good response. The ΔADC during was significantly higher in pathCR patients compared to patients without pathCR, as well as in good responders compared to poor responders (Table 1, Figure 1-3) . Initial tumor ADC and ΔADC post were not significantly related to pathologic response. ROC analysis for ΔADC during resulted in an area under the curve (AUC) of 0.90 for discriminating pathCR from no pathCR at an optimal cut-off value of 28.9% (sensitivity 100%, specificity 75%, accuracy 95%, PPV 94%, and NPV 100%). For discriminating good from poor responders, ΔADC during showed an AUC of 0.92 with an optimal cut-off value of 20.7% (sensitivity 82%, specificity 100%, accuracy 89%, PPV 100%, and NPV 80%).
Conclusions:
The treatment-induced change in ADC as determined on DW-MRI during the first 2-3 weeks of nCRT for esophageal cancer allows for accurate early prediction of pathologic response. The high sensitivity and NPV of ΔADC during for predicting residual cancer are particularly promising when considering a patient-tailored wait-and-see approach with omission of surgery in the future. The high specificity and PPV of ΔADC during for predicting poor response are promising for future considerations regarding modification or discontinuation of nCRT early during treatment. Purpose/Objective: The purpose of the current study was to investigate the ability of pre-treatment factors and response signals extracted from standard CBCT images obtained during fractionated radiotherapy to predict the lung radioresponsiveness (LuRa) measured as density changes in follow-up CT scans for NSCLC patients. Materials and Methods: Follow-up CT scans acquired within 6 months after commencement of radiotherapy (RT) were evaluated for 135 NSCLC patients treated with CBCT image guided RT to 60 or 66 Gy in 2 Gy fractions. Dose-effect curves were produced from follow-up CT scans by relating changes in regional lung density to regional planned dose using deformable image registration. LuRa was defined as the slope of a linear fit to the dose-effect curve and provides an objective measure of the patients' individual susceptibility to radiation. Cone beam signals (CBS) were obtained by analysing changes in lung density in CBCT images acquired during the treatment course. The association of LuRa with pre-treatment factors and CBS was investigated in terms of overall correlations and for the ability to predict subgroups of patients with high or low responsiveness. Results: LuRa values range from -1.1 to 6.2 HU/Gy with a median at 1.0 HU/Gy. Of the pre-treatment factors, age correlated most with LuRa on univariable analysis (R=0.31). CBS obtained at the 20th and 30th treatment fraction was significantly correlated with LuRa (R=0.19 and R=0.34, respectively), while the signal obtained at the 10th fraction only reached borderline significance (R=0.16, p=0.068). Age and CBS extracted at 10th, 20th, and 30th treatment fraction were significant in multivariable analysis and a set of models for predicting LuRa based on these parameters were established (see table) . Due to the low correlations, the models might have limited clinical impact. However, for typical treatments ~15% of the patients experience a grade 3+ pneumonitis, and the right-sided tail of the LuRa values contains ~15% of the data as well. Thus, a dichotomization of the LuRa values at 85% (2.7 HU/Gy) might be clinically relevant. The ability of the 10 th fraction model to predict a low response in patients is visualized as ROC curves in the figure. For safe dose escalation, all high-responsive patients must be classified correctly. In this regime (specificity=1), the full model classified significantly more of the lowresponsive patients correctly than the model only including age (58% vs. 36%, p<0.001).
This study indicates that the effect of radiation dose on the local lung damage may be partially detected already during RT using CBCT image analysis. If a high LuRa value is shown to be a good surrogate endpoint for clinical toxicity and the results of the current investigational study are validated, the proposed response models may provide an assay for identifying a subgroup of low-responsive patients as potential candidates for safe dose escalation.
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The promise of functional volume automatic segmentation D. Visvikis 1 1 INSERM U650 LaTIM, Medical Physics, Brest, France Accurate, robust, reproducible and fast delineation of functional tumor volumes in 3D using positron emission tomography (PET) has been already identified as a pressing challenge for an increasing number of oncology applications, such as image-guided radiotherapy, as well as diagnosis, prognosis and therapy response assessment. The main drive behind this interest is based on the fact that the use of functional imaging allows the biological characterization of active tumor volumes employing different tracers. There is therefore a growing need for accurate quantification of both tumor volume and associated indices of tracer accumulation, such as standardized uptake values, in order to refine detection criteria associated with various forms of cancer and study the relationship between overall tumor burden and response to therapy or survival. Following the introduction of the main clinical incentives behind the development of functional volume segmentation algorithms, the objectives of this presentation will be to (a). provide a critical analysis of the currently available segmentation methods and associated validation studies, (b). provide guidelines with respect to the clinical use of existing semi-automatic and fully-automatic algorithms, (c). discuss the impact of automatic functional segmentation algorithms within the context of therapy response monitoring and radiotherapy treatment planning.
SP-0627 Online therapy refinement and reoptimisation of treatment plans U. Oelfke 1 1 The Institute of Cancer Research and the Royal Marsden NHS Trust, Joint Department of Physics, London, United Kingdom
Temporal changes of the location and shape of tumour targets or organs at risk during a course of treatment are considered one of the major obstacles to deliver high precision radiation therapy (RT) for a number of treatment sites. According to the different time scales on which these organ movements and deformations are expected to occur one differentiates between inter-and intra-fraction organ motions. One basic strategy to account for the effect of anatomical changes during RT refers to treatment plan adaptation that can be either achieved as the refinement of an existing treatment plan or as complete re-optimisation of treatment parameters for the new patient geometry. The standard scenario envisioned for a clinical workflow is based on a set of 3d-images of the patient in treatment position directly prior to treatment acquired either by inroom imaging devices, ranging from in-room kV-CT, MV-CBCT, kV-CBCT or MV-CT to MRI. These images are then prepared for either treatment plan modification or replanning by fast image processing that identifies the actual volumes of interest relevant for autmatic plan optimisation. These methods were originally designed for off-line modifications of established treatment plans to account for slowly developing anatomical changes like weight loss/gain of patients or radiation induced tissue responses. However, improved soft tissue contrast, especially achievable with MRI combined with ultra-fast treatment planning tools will allow to extend the application of this treatment adaptation strategy to the on-line regime, i.e., either directly prior to treatment or even during treatment. We will discuss the development and application of on-line treatment plan adaptation tools for inter-and intra-fraction changes of the patient anatomy. Starting point will be a dynamic patient model (DPM) which will be continously updated through images acquired during the course of treatment. The DPM can be used to re-construct the delivered dose to the patient, before a new treatment plan is established. This second step can be either achieved by interactive refinement of an existing treatment plan via a graphical interface or by a complete re-optimisation. Both approaches require a different approach of online quality assurance. Furthermore, we will discuss the scenario of an online feedback loop between real-time plan adaptation and dynamic dose delivery concepts.
SP-0628 Knowledge based: new planning perspectives A. Fogliata 1 1 Humanitas Research Center, Radiotherapy and Radiosurgery, Rozzano / Milan, Italy
Intensity modulated treatments, in the two forms or IMRT with fixed fields and VMAT (volumetric modulated arc therapy) with rotational approach, is possible only thanks to the inverse process for planning the treatments. This opens the challenge to translate the desired dose distributions, including the broad knowledges on the toxicity dose levels for the critical structures, into the proper dose-volume
